Correlation
The correlation between RPRX and TBUX is 0.09, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
RPRX vs. TBUX
Compare and contrast key facts about Royalty Pharma plc (RPRX) and T. Rowe Price Ultra Short-Term Bond ETF (TBUX).
TBUX is an actively managed fund by T. Rowe Price. It was launched on Sep 28, 2021.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: RPRX or TBUX.
Performance
RPRX vs. TBUX - Performance Comparison
Loading data...
Key characteristics
RPRX:
1.17
TBUX:
4.18
RPRX:
1.83
TBUX:
7.07
RPRX:
1.24
TBUX:
1.99
RPRX:
0.55
TBUX:
17.96
RPRX:
4.50
TBUX:
72.89
RPRX:
6.01%
TBUX:
0.08%
RPRX:
24.41%
TBUX:
1.43%
RPRX:
-49.68%
TBUX:
-1.79%
RPRX:
-30.95%
TBUX:
-0.04%
Returns By Period
In the year-to-date period, RPRX achieves a 30.61% return, which is significantly higher than TBUX's 2.19% return.
RPRX
30.61%
1.91%
24.98%
23.51%
-4.75%
N/A
N/A
TBUX
2.19%
0.52%
2.48%
5.90%
5.29%
N/A
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
RPRX vs. TBUX — Risk-Adjusted Performance Rank
RPRX
TBUX
RPRX vs. TBUX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Royalty Pharma plc (RPRX) and T. Rowe Price Ultra Short-Term Bond ETF (TBUX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
RPRX vs. TBUX - Dividend Comparison
RPRX's dividend yield for the trailing twelve months is around 2.62%, less than TBUX's 5.18% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
RPRX Royalty Pharma plc | 2.62% | 3.29% | 2.85% | 1.92% | 1.71% | 0.60% |
TBUX T. Rowe Price Ultra Short-Term Bond ETF | 5.18% | 5.39% | 4.66% | 2.58% | 0.27% | 0.00% |
Drawdowns
RPRX vs. TBUX - Drawdown Comparison
The maximum RPRX drawdown since its inception was -49.68%, which is greater than TBUX's maximum drawdown of -1.79%. Use the drawdown chart below to compare losses from any high point for RPRX and TBUX.
Loading data...
Volatility
RPRX vs. TBUX - Volatility Comparison
Royalty Pharma plc (RPRX) has a higher volatility of 7.62% compared to T. Rowe Price Ultra Short-Term Bond ETF (TBUX) at 0.44%. This indicates that RPRX's price experiences larger fluctuations and is considered to be riskier than TBUX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...